Emil D. Kakkis - Dec 31, 2021 Form 5 Insider Report for Ultragenyx Pharmaceutical Inc. (RARE)

Role
President & CEO, Director
Signature
/s/ Karah Parschauer, attorney-in-fact
Stock symbol
RARE
Transactions as of
Dec 31, 2021
Transactions value $
$0
Form type
5
Date filed
2/1/2022, 12:41 PM
Previous filing
Oct 18, 2021
Next filing
Mar 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RARE Common Stock Gift $0 -50K -2.21% $0.00 2.21M Dec 10, 2021 By Emil Kakkis and Jenny Soriano Living Trust, dated June 18, 200
holding RARE Common Stock 594K Dec 31, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.